脑动极光(06681)续升超77% 两日股价翻倍 公司将脑科学与AI结合 开发针对认知障碍的数字疗法产品

金吾财讯
Sep 15

金吾财讯 | 脑动极光-B(06681)延续升势,截至发稿,涨超77%,报13.32港元,较两个交易日前股价翻倍。需要注意的是,该股于上周五收涨32.28%。截至当前,消息面上,从技术层面来看,脑机接口技术近年已取得了突破性进展。当地时间9月9日,马斯克旗下的脑机植入技术公司Neauralink宣布,全球已有12人接受了其研发的脑机芯片N1植入试验。Neuralink称,这些患者总共使用其设备达2000天,累计使用时长超过15000小时。据悉,公司是中国首家将脑科学与先进的人工智能技术相结合,开发出针对认知障碍的医疗级数字疗法产品的公司。公司的产品管线涵盖由血管疾病、神经退行性疾病、精神障碍及儿童发育缺陷等诱发的广泛的认知障碍的测评和干预。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10